Skip to main content
You're viewing the free public version. Create a free account for full research and member tools. Join free
Research Abstract Animal Study

Synergistic effects of Coptis rhizome and rhubarb in inhibiting MDA-MB-231 triple-negative breast cancer metastasis.

Synergistic effects of Coptis rhizome and rhubarb in inhibiting MDA-MB-231 triple-negative breast cancer metastasis: Potential involvement of coptisine and resveratroloside.

0:00 / 0:00
0:00 / 0:00

Sign in to access this feature

Create a free account or sign in to use AI summaries, listen to articles, download PDFs, and save to your library.

222 views
Share:

Abstract

Metastasis, particularly in aggressive triple-negative breast cancer (TNBC), is the leading cause of breast cancer-related mortality. San-Huang-Xie-Xin-Tang (SHXXT), a heat-clearing herbal formula, is commonly prescribed by Chinese medicine physicians to treat breast cancer patients, and our previous study found that its treatment was associated with reduced mortality in these patients. To further explore its therapeutic potential, we investigated the combined effect of its key ingredients, Coptis rhizome and rhubarb, on the metastasis of TNBC by using MDA-MB-231 cell line. Data showed that the water extract of SHXXT reduced cell migration without inducing cell death, and oral administration of Coptis rhizome and rhubarb extracts significantly suppressed metastasis in vivo. Notably, this combination exhibited a potent synergistic inhibitory effect on cell migration and invasion, with a combination index of 0.2. Further analysis identified coptisine and resveratroloside as key active compounds that synergistically inhibit cell mobility. They modulate divergent epithelial-to-mesenchymal transition-related protein expressions, and this complementary regulation may underlie their synergistic effect. Taken together, our findings demonstrate that the water extracts of Coptis rhizome and rhubarb synergistically inhibit metastatic property of TNBC cells, with coptisine and resveratroloside contributing to this effect at least partly, suggesting their potential for the development of new adjuvant therapies for TNBC treatment.

Affiliation

Yun-Hao Dai

External References

PubMed ID:
40744130

Comments

Sign in or create a free account to join the conversation.

Sign in to comment

Be the first to comment.

More Research Abstracts

View All Abstracts

Trusted By Professionals and Teams:

The National Health Federation
Stand For Health Freedom
Global Healing Institute
Global Wellness Forum
MAHA Action
Myers Detox
Natural News
Mercola.com

Unlock Evidence-Based Health Research

Join 500,000+ members accessing 10,000+ natural health topics.

Subscribe to our informative Newsletter & Receive

Cancer Fighting Foods Ebook

Our newsletter serves 500,000 with essential news, research & healthy tips, daily.

Disclaimer: This article is not intended to provide medical advice, diagnosis or treatment. Views expressed here do not necessarily reflect those of GreenMedInfo or its staff.